The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus

Jia-An Teng(The People's Hospital of Guangxi Zhuang Autonomous Region), Zhen‐Yu He(Wuhan University of Technology)

PLoS ONE

February 22, 2016

10.1371/journal.pone.0149822

Cited by 48

Related Papers

Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment

|JAMA|2020|229